Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

Dose escalating study of biweekly gemcitabine and carboplatin in patients with advanced cancer.

Dudek AZ, Larson T, Keshtgarpour M, Kumar P.

Am J Clin Oncol. 2007 Oct;30(5):481-6.

PMID:
17921707
3.

A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer.

Tomizawa Y, Ishihara S, Iijima H, Imai H, Sato K, Yatomi M, Iwasaki Y, Yamada H, Kobayashi G, Ishida E, Inoue T, Aoki H, Watanabe S, Kawashima O, Mori M, Saito R.

Am J Clin Oncol. 2007 Oct;30(5):498-502.

PMID:
17921710
4.
5.

Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial.

Tassinari D, Drudi G, Panzini I, Pasini G, Arcangeli V, Fochessati F, Gianni L, Mianulli AM, Oliverio G, Pasquini E, Sartori S, Ravaioli A.

Int J Clin Oncol. 2001 Dec;6(6):279-83.

PMID:
11828946
6.

Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.

Gajra A, Mehdi SA, Kirshner J, Newman N, Graziano SL.

Lung Cancer. 2001 May;32(2):189-96.

PMID:
11325490
7.

Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.

Langer CJ, Leighton JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF.

Semin Oncol. 1995 Aug;22(4 Suppl 9):18-29.

PMID:
7544025
8.

A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): a hoosier oncology group study.

Ng EW, Sandler AB, Robinson L, Einhorn LH.

Am J Clin Oncol. 1999 Dec;22(6):550-3.

PMID:
10597737
9.

Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer.

Robert F, Blumenschein G, Herbst RS, Fossella FV, Tseng J, Saleh MN, Needle M.

J Clin Oncol. 2005 Dec 20;23(36):9089-96. Epub 2005 Nov 21.

PMID:
16301597
10.

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study.

Soo RA, Lim HL, Wang LZ, Lee HS, Millward MJ, Tok LT, Lee SC, Lehnert M, Goh BC.

Cancer Chemother Pharmacol. 2003 Aug;52(2):153-8. Epub 2003 May 16.

PMID:
12750842
11.

The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.

Davies AM, Ruel C, Lara PN, Lau DH, Gumerlock PH, Bold R, Shibata S, Lenz HJ, Schenkein DP, Gandara DR.

J Thorac Oncol. 2008 Jan;3(1):68-74. doi: 10.1097/JTO.0b013e31815e8b88.

12.

Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase I study.

Athanasiadis A, Roussos G, Papakostoulis T, Athanasiadou DC, Stathopoulos GP.

Cancer Chemother Pharmacol. 2005 Dec;56(6):653-8. Epub 2005 Jun 4.

PMID:
15937714
13.

Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug delivery.

Abratt RP, Sandler A, Crinò L, Steward WP, Shepherd FA, Green MR, Nguyen B, Peters GJ.

Semin Oncol. 1998 Aug;25(4 Suppl 9):35-43.

PMID:
9728583
14.

Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy.

Flaherty KT, Stevenson JP, Hahn SM, Redlinger M, O'Dwyer PJ.

Cancer Chemother Pharmacol. 2003 Sep;52(3):217-22. Epub 2003 Jun 17.

PMID:
12811513
15.

A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.

Hensley ML, Dizon D, Derosa F, Venkatraman E, Sabbatini P, Chi DS, Dupont J, Colevas AD, Spriggs D, Aghajanian C.

Invest New Drugs. 2007 Aug;25(4):335-41. Epub 2007 Mar 16.

PMID:
17364235
16.

Gemcitabine/carboplatin in a modified 21-day administration schedule for advanced-stage non-small-cell lung cancer.

Yoshimura M, Imamura F, Ueno K, Uchida J.

Clin Lung Cancer. 2006 Nov;8(3):208-13.

PMID:
17239297
17.

Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.

Langer CJ, Millenson M, Rosvold E, Litwin S, McAleer CA, Bonjo CA, Ozols R.

Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-81-S12-88.

PMID:
9331128
18.

Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.

Langer CJ, Leighton J, McAleer C, Comis R, O'Dwyer P, Ozols R.

Semin Oncol. 1995 Jun;22(3 Suppl 6):64-9.

PMID:
7541156
19.

Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer.

Nasr FL, Chahine GY, Kattan JG, Farhat FS, Mokaddem WT, Tueni EA, Dagher JE, Ghosn MG.

Clin Breast Cancer. 2004 Jun;5(2):117-22; discussion 123-4.

PMID:
15245614
20.

A phase I study of gemcitabine and carboplatin in non-small cell lung cancer.

Carmichael J, Allerheiligen S, Walling J.

Semin Oncol. 1996 Oct;23(5 Suppl 10):55-9.

PMID:
8893883

Supplemental Content

Support Center